We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Molecular mechanisms governing antifungal drug resistance

    Fungal pathogens are a severe public health problem. The leading causative agents of systemic fungal infections include species from the Candida , Cryptococcus...

    Yunjin Lee, Nicole Robbins, Leah E. Cowen in npj Antimicrobials and Resistance
    Article Open access 17 July 2023
  2. Exploring the Potential of Farnesol as a Novel Antifungal Drug and Related Challenges

    Purpose of Review

    Farnesol (FOH) is a quorum-sensing molecule with potential as an antifungal drug. Given the growing concern about fungal drug...

    Dongming Zheng, Linlan Yang, ... Yan Li in Current Infectious Disease Reports
    Article 26 February 2024
  3. Systemic Antifungal Agents

    Systemic antifungal drugs used to treat serious fungal disease fall chiefly into three drug classes—azoles, echinocandins, and polyenes. A fourth...
    Russell E. Lewis, Nathan P. Wiederhold in Diagnosis and Treatment of Fungal Infections
    Chapter 2023
  4. Drug Target Elucidation Through Isolation and Analysis of Drug-Resistant Mutants in Cryptococcus neoformans

    Drug target identification is an essential component to antifungal drug development. Many methods, including large chemical library screening,...
    Michael J. Hoy, Joseph Heitman in Antifungal Drug Resistance
    Protocol 2023
  5. New Antifungal Drugs: Discovery and Therapeutic Potential

    There has been an increase in invasive fungal infections, which are a universal problem due to the longer average lifespan, the number of...
    Francisca Vicente, Fernando Reyes, Olga Genilloud in Fungi Bioactive Metabolites
    Chapter 2024
  6. Synthesis, structure-activity relationship and evaluation of antifungal activity of tryptanthrin derivatives against drug-resistant Candida albicans

    With the increasing of Candida albicans infections year by year, and the widespread use of azole drugs, especially fluconazole has led to the...

    Yandan Wu, Luyi Jiang, ... Guanghui Ni in Medicinal Chemistry Research
    Article 04 July 2024
  7. Isolation of antimicrobial ellagic acid from endophytic fungi and their target-specific drug design through computational docking

    In recent decades, there has been a dramatic increase in fundamental microbial disease pervasiveness. The evolution of multi-drug resistant organisms...

    Basavaraju Sumanth, Fazilath Uzma, ... Sudisha Jogaiah in Biomass Conversion and Biorefinery
    Article 19 July 2024
  8. New Systemic Antifungal: Isavuconazole

    Invasive fungal infections have been increasing with the increased use of immunosuppressive drugs for the treatment of cancer, organ, stem cell and...
    Chapter 2023
  9. Hydroxychloroquine an Antimalarial Drug, Exhibits Potent Antifungal Efficacy Against Candida albicans Through Multitargeting

    Candida albicans is the primary etiological agent associated with candidiasis in humans. Unrestricted growth of C. albicans can progress to systemic...

    Sargun Tushar Basrani, Tanjila Chandsaheb Gavandi, ... Ashwini Khanderao Jadhav in Journal of Microbiology
    Article 08 April 2024
  10. Heterologous Expression of Candida Antifungal Target Genes in the Model Organism Saccharomyces cerevisiae

    Understanding how a gene variant may influence antifungal resistance, or other phenotypic characteristics, is an important step in determining or...
    Kelley R. Healey, Ashutosh Singh in Antifungal Drug Resistance
    Protocol 2023
  11. Exploiting response surface D-optimal design study for preparation and optimization of spanlastics loaded with miconazole nitrate as a model antifungal drug for topical application

    Purpose

    Skin fungal infections are widely spreading worldwide and are considered a main cause of skin, mucous membranes, and systemic diseases. In an...

    Mervat Shafik Ibrahim, Omar A. Elkady, ... Shereen H. Noshi in Journal of Pharmaceutical Innovation
    Article Open access 30 November 2023
  12. Oxidative effects of the human antifungal drug clotrimazole on the eucaryotic model organism Saccharomyces cerevisiae

    Clotrimazole is a type of antifungal medication developed from azole compounds. It exhibits several biological actions linked to oxidative stress....

    Berna Kavakcıoğlu Yardımcı, Leman Tarhan in Archives of Microbiology
    Article 07 June 2024
  13. Advanced Vesicular Systems for Antifungal Drug Delivery

    Fungal infections are considered one of the most serious conditions as their occurrence has increased lately. Fungi like Candida , Fusarium , and Aspergillus...

    Shaimaa Mosallam, Rofida Albash, Manar Adel Abdelbari in AAPS PharmSciTech
    Article Open access 28 July 2022
  14. A dual-targeting antifungal is effective against multidrug-resistant human fungal pathogens

    Drug-resistant fungal infections pose a significant threat to human health. Dual-targeting compounds, which have multiple targets on a single...

    Min Zhou, Longqiang Liu, ... Runhui Liu in Nature Microbiology
    Article 08 April 2024
  15. Antifungal Stewardship Interventions in Patients with Hematologic Malignancies

    Purpose of Review

    Antifungal stewardship has been recognized as a significant component of any antimicrobial stewardship program. In this article, we...

    Paschalis Vergidis, Ryan W. Stevens, Samir G. Agrawal in Current Fungal Infection Reports
    Article Open access 24 May 2023
  16. Evaluation of the efficacy of heat shock protein inhibitors and antifungal drug combinations against Candida spp.

    Candida species are one of the predominant causes of fungal infections and show drug-resistant infections in immune-compromised individuals....

    Nuri Kiraz, Sümeyye Şen Kaya, ... İlknur Dağ in Rendiconti Lincei. Scienze Fisiche e Naturali
    Article 20 December 2022
  17. Epidemiological trends, antifungal drug susceptibility and SQLE point mutations in etiologic species of human dermatophytosis in Al-Diwaneyah, Iraq

    Dermatophytes show a wide geographic distribution and are the main causative agents of skin fungal infections in many regions of the world. Recently,...

    Hussein R. Mahmood, Masoomeh Shams-Ghahfarokhi, ... Mehdi Razzaghi-Abyaneh in Scientific Reports
    Article Open access 03 June 2024
  18. Nanoparticles assisted intra and transdermic delivery of antifungal ointment: an updated review

    This review paper highlights the trans-dermic delivery of nanoparticles (NPs) based antifungal ointments with the help of nanotechnology. It also...

    Nazia Tarannum, Km. Pooja, ... Anshika Mavi in Discover Nano
    Article Open access 09 January 2024
  19. Drug to genome to drug: a computational large-scale chemogenomics screening for novel drug candidates against sporotrichosis

    Sporotrichosis is recognized as the predominant subcutaneous mycosis in South America, attributed to pathogenic species within the Sporothrix genus....

    Andressa Santana Santos, Vinícius Alexandre Fiaia Costa, ... Bruno Junior Neves in Brazilian Journal of Microbiology
    Article 18 June 2024
  20. Target identification of small molecules: an overview of the current applications in drug discovery

    Target identification is an essential part of the drug discovery and development process, and its efficacy plays a crucial role in the success of any...

    Yasser Tabana, Dinesh Babu, ... Khaled Barakat in BMC Biotechnology
    Article Open access 10 October 2023
Did you find what you were looking for? Share feedback.